Nyxoah Announces U.S. FDA Breakthrough Device Designation Granted for the Genio® System for Obstructive Sleep Apnea and Complete Concentric Collapse

来源: Nasdaq GlobeNewswire / 14 9月 2021 02:00:00   America/New_York